Table 1. Baseline characteristics, management, and outcome of COVID-19 patients.
| Patients | n | % |
|---|---|---|
| Demographics | ||
| Age, n (mean ± SD) | 584 (52.9 ± 15.7) | 100 |
| Male | 398 (51.0 ± 15.2) | 68.2 |
| Female | 186 (57.0 ± 16.2) | 31.8 |
| Comorbidities | ||
| Hypertension | 275 | 47.1 |
| Diabetes mellitus | 257 | 44.0 |
| Obesity | 100 | 17.1 |
| Chronic kidney disease | 78 | 13.4 |
| Chronic cardiac disease | 73 | 12.5 |
| Rheumatological disease | 48 | 8.2 |
| Chronic neurological disease | 35 | 6.0 |
| Chronic pulmonary disease | 27 | 4.6 |
| Current malignancy | 22 | 3.8 |
| Solid organ transplant | 20 | 3.4 |
| Chronic liver disease | 18 | 3.1 |
| Symptoms at the admission | ||
| Fever | 400 | 68.5 |
| Shortness of breath | 394 | 67.5 |
| Cough | 349 | 59.8 |
| Diarrhea | 141 | 24.1 |
| Chest pain | 120 | 20.5 |
| Muscle aches | 112 | 19.2 |
| Sore throat | 58 | 9.9 |
| Ward type admission and treatment | ||
| General ward | 308 | 52.7 |
| Intensive care unit | 276 | 47.3 |
| Invasive mechanical ventilation | 218 | 37.3 |
| Antibiotics on admission | 543 | 93.0 |
| Inpatients mortality | 118 | 20.2 |
| Length of stay, days | 12.6 ± 13.8 | |
| Laboratory parameters at the admission | Reference value | Mean ± SD |
| White blood cells | 2.2–10 × 109/L | 8.2 ± 5.8 |
| Absolute neutrophil count | 1–5 × 109/L | 6.3 ± 4.5 |
| Absolute lymphocyte count | 1.2–4 × 109/L | 1.6 ± 1.2 |
| C-reactive protein | < 10 mg/L | 119.0 ± 87.6 |
| Ferritin | 48–708 μg/L | 1537.3 ± 3584.7 |